• PMID: 10522996
• Gene Name: DAX1
• Condition: Adrenal hypoplasia congenita, hypogonadotropic hypogonadism (HH)
• Association: The results suggest that the hypogonadism is due to a combined hypothalamic-pituitary-gonadal defect and imply that the DAX-1 gene may play a critical role in human testicular function.
• PMID: 10522996
• Gene Name: DAX1
• Condition: Adrenal hypoplasia congenita and hypogonadotropic hypogonadism (HH)
• Association: In conclusion, we report a novel mutation in the DAX-1 gene in patients with AHC and HH. The results suggest that the hypogonadism is due to a combined hypothalamic-pituitary-gonadal defect and imply that the DAX-1 gene may play a critical role in human t
• Mutation: C to A transversion at nucleotide 825 in the DAX-1 gene, resulting in a stop codon at position 197
• Population size: 1
• Population details: 1 male patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism (HH)
• Age: 20-yr-old
• Sex: Male
• Infertility type: Male infertility
• Other associated phenotypes: Adrenal hypoplasia congenita and hypogonadotropic hypogonadism (HH)

Combined hypothalamic-pituitary-gonadal defect in a hypogonadic man with a novel mutation in the DAX-1 gene

Caron P, Imbeaud S, Bennet A, Plantavid M, Camerino G, Rochiccioli P.

We have studied a 20-yr-old male patient with adrenal hypoplasia congenita and hypogonadotropic hypogonadism (HH) due to a C to A transversion at nucleotide 825 in the DAX-1 gene, resulting in a stop codon at position 197. The same mutation was detected in his affected first cousin (adrenal hypoplasia congenita and HH) and in a heterozygous state in their carrier mothers. The patient had had acute adrenal insufficiency at the age of 2 yr and 6 months, bilateral cryptorchidism corrected surgically at the age of 12 yr, and failure of spontaneous puberty. Plasma testostereone (T) was undetectable (<0.30 nmol/L), gonadotropin levels were low (LH, <0.4 IU/L; FSH, 1.5 IU/L) and not stimulated after i.v. injection of 100 microg GnRH. The endogenous LH secretory pattern was apulsatile, whereas free alpha-subunit (FAS) levels depicted erratic pulses, suggesting an incomplete deficiency of hypothalamic GnRH secretion. During i.v. pulsatile GnRH administration (10 microg/pulse every 90 min for 40 h), each GnRH pulse induced a LH response of low amplitude (0.54 +/- 0.05 UI/L), whereas mean LH (0.45 +/- 0.01 IU/L) and FAS (63 +/- 8 mU/L) levels remained low. Amplitude of LH peaks (0.83 +/- 0.09 IU/L), mean LH (0.53 +/- 0.02 IU/L), and FAS (161 +/- 18 mU/L) levels increased (P < 0.01), whereas the T concentration remained low (0.75 nmol/L) when the pulsatile GnRH regimen was raised to 20 microg/pulse for a 40-h period, suggesting a partial pituitary resistance to GnRH. Thereafter, plasma T levels remained in prepubertal value after three daily im injections of 5000 IU hCG (3.6 nmol/L) and after 1-yr treatment with weekly i.m. injections of 1500 IU hCG (1.2 nmol/L), implying Leydig cell resistance to hCG. The patient had a growth spurt, bone maturation, progression of genital and pubic hair stages, and normalization of plasma T level (15.8 nmol/L) after a 12-month treatment with twice weekly injections of hCG and human menopausal gonadotropin (75 IU International Reference Preparation 2) preparations, suggesting that, in presence of FSH, a Sertoli cell-secreted factor stimulated Leydig cell production of T. In conclusion, we report a novel mutation in the DAX-1 gene in patients with AHC and HH. Our results suggest that the hypogonadism is due to a combined hypothalamic-pituitary-gonadal defect and imply that the DAX-1 gene may play a critical role in human testicular function. FAU - Caron, P AU - Caron P AD - Service d'Endocrinologie et Maladies Métaboliques, CHU Rangueil, Toulouse, France. caron.p@chu-toulouse.fr FAU - Imbeaud, S AU - Imbeaud S FAU - Bennet, A AU - Bennet A FAU - Plantavid, M AU - Plantavid M FAU - Camerino, G AU - Camerino G